Page 5 - வெற்றி புற்றுநோய் நிறுவனம் ஆஃப் உணர்ச்சி பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வெற்றி புற்றுநோய் நிறுவனம் ஆஃப் உணர்ச்சி பல்கலைக்கழகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வெற்றி புற்றுநோய் நிறுவனம் ஆஃப் உணர்ச்சி பல்கலைக்கழகம் Today - Breaking & Trending Today

Chemo may not benefit all postmenopausal women with breast cancer


Some postmenopausal women with breast cancer do not benefit from chemotherapy when it’s added to hormone therapy, according to initial results of a clinical trial.
The findings apply to postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has spread to a limited number of lymph nodes, and whose recurrence risk is relatively low.
The findings may save tens of thousands of postmenopausal women each year the time, money, and harmful side effects that come with chemotherapy infusions.
This is the first evidence in a randomized phase III trial that postmenopausal women with HR-positive, HER2-negative breast cancer that has spread to one to three lymph nodes can safely forgo chemotherapy if their recurrence score on a genomic tumor tissue test is 25 or less. ....

San Antonio , United States , Larissa Korde , Susang Komen , Kevin Kalinsky , Breast Cancer Research Foundation , National Clinical Trials Network , National Cancer Institute , Cure Research Program , Cancer Therapy Evaluation Program , Winship Cancer Institute Of Emory University , Glenn Family Breast Center , Hope Foundation For Cancer Research , Cancer Research Network , Winship Cancer Institute , Breast Cancer , Melanoma Therapeutics , Therapy Evaluation , Antonio Breast Cancer , Research Network , Clinical Trials , Hope Foundation , Cancer Research , Exact Sciences , சான் அன்டோனியோ , ஒன்றுபட்டது மாநிலங்களில் ,